TABLE 4 .
Dockerin | Interaction |
Associated domain(s) | |||
---|---|---|---|---|---|
Coh1 (Amy4) | Coh2 (Sca2) | Coh3 (Sca3) | Coh4 (Sca4) | ||
Amy9 | +++++ | +++ | +++++ | +++++ | GH13 |
CBL16032.1 | +++ | ++ | +++++ | +++++ | Peptidase |
CBL14720.1 | +++++ | +++ | +++++ | +++++ | 2× LRR |
Amy4 | ++++ | +++ | +++++ | +++++ | GH13, Coh1 |
Amy10 | +++++ | + | +++++ | +++++ | GH13, CBM26, CBM48 |
CBL14834.1 | +++++ | +++ | +++++ | +++++ | |
CBL14836.1 | − | − | − | + | Cysteine protease |
CBL15647.1 | − | − | − | − | |
Amy12 | − | − | ++ | +++++ | GH13, CBM48 |
CBL15625.1 | − | − | − | − | |
CBL16049.1 | − | − | − | − |
Proteins were expressed as recombinant products (CBM fusions [cohesins] and XYN fusions [dockerins]) in E. coli (see Materials and Methods). LRR, = leucine-rich repeat. +++++, very strong; ++++, strong; +++, moderate; ++, weak; +, very weak; −, none.